Two Sigma Investments, LP Hcw Biologics Inc. Call Options Transaction History
Two Sigma Investments, LP
- $42.8 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HCWB
# of Institutions
16Shares Held
1.16MCall Options Held
0Put Options Held
0-
Avantax Planning Partners, Inc.280KShares$1.86 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA243KShares$1.62 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA237KShares$1.58 Million0.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$877,7330.01% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL75.1KShares$499,5210.01% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $238M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...